The use of autologous skeletal muscle progenitor cells for adjunctive treatment of presumptive urethral sphincter mechanism incompetence in female dogs
Journal of Veterinary Internal Medicine2022Vol. 36(5), pp. 1686–1692
Citations Over Time
Shelly L. Vaden, Kyle G. Mathews, James J. Yoo, J. Koudy Williams, Tonya Harris, Patty Secoura, James Robertson, Katherine Gleason, Hannah M. Reynolds, Jorge A. Piedrahita
Abstract
Urethral submucosal injection of skMPC can be used adjunctively to improve continence in dogs with difficult to manage USMI. The procedure is labor intensive but well tolerated; most dogs will require continued medication to remain continent.
Related Papers
- → The Maximal Urethral Pressure at Rest and during Normal Bladder Filling Is Only Determined by the Activity of the Urethral Smooth Musculature in the Female(2023)13 cited
- → A canine model of irreversible urethral sphincter insufficiency(2008)42 cited
- → Clear cell adenocarcinoma of female urethra: A case report(2018)6 cited
- → SURGICAL THERAPY FOR ABNORMALITIES OF THE URINARY SPHINCTER IN THE FEMALE1(1965)21 cited
- → The anatomy of the external striated urethral sphincter(1972)14 cited